Cargando…
Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas
SIMPLE SUMMARY: Gliomas are the most common malignant brain tumors with high mortality rates. Recently the role of the FREM2 gene has been shown in glioblastoma progression. Here we reconstructed the FREM2 molecular pathway. We assessed the biomarker capacity of FREM2 expression and its pathway as t...
Autores principales: | Zolotovskaia, Marianna, Tkachev, Victor, Sorokin, Maxim, Garazha, Andrew, Kim, Ella, Kantelhardt, Sven Rainer, Bikar, Sven-Ernö, Zottel, Alja, Šamec, Neja, Kuzmin, Denis, Sprang, Bettina, Moisseev, Alexey, Giese, Alf, Efimov, Victor, Jovčevska, Ivana, Buzdin, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394245/ https://www.ncbi.nlm.nih.gov/pubmed/34439271 http://dx.doi.org/10.3390/cancers13164117 |
Ejemplares similares
-
High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas
por: Jovčevska, Ivana, et al.
Publicado: (2019) -
Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates
por: Vidak, Marko, et al.
Publicado: (2018) -
Non-animal glioblastoma models for personalized treatment
por: Zottel, Alja, et al.
Publicado: (2023) -
Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs
por: Zottel, Alja, et al.
Publicado: (2020) -
Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
por: Šamec, Neja, et al.
Publicado: (2020)